GlassScriptPhysician profile
Justine Ann Bello
NPI 1629237276
$1,083.17
in general payments reported to CMS, 2019-2025
17 companies · $474 in 2025
The $474 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2020: $48.46 · 2021: $21.54 · 2022: $43.69 · 2023: $140 · 2024: $330 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $191.43 | 2020-2025 | Arexvy, Shingrix |
| Novo Nordisk INC | $100.48 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $94.62 | 2024-2025 | Airsupra |
| Dexcom, INC. | $88.48 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $84.79 | 2024-2025 | |
| Pfizer INC. | $82.86 | 2022-2025 | |
| Abiomed | $77.70 | 2025 | |
| Lilly USA, LLC | $63.71 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Edwards Lifesciences Corporation | $61.91 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $55.80 | 2024-2025 | Otezla, Repatha, Repatha |
| Boston Scientific Corporation | $40.73 | 2024 | |
| Exact Sciences Corporation | $34.05 | 2023-2024 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Inari Medical, INC. | $24.96 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon INC. | $22.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $18.72 | 2023 | |
| Gilead Sciences, INC. | $15.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justine Bello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.